T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome

被引:39
作者
Dahle, C [1 ]
Ekerfelt, C
Vrethem, M
Samuelsson, M
Ernerudh, J
机构
[1] Linkoping Univ Hosp, Dept Neurol, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Transfus Med & Clin Immunol, S-58185 Linkoping, Sweden
[3] Cty Hosp, Dept Neurol, S-71085 Orebro, Sweden
关键词
Guillain-Barre syndrome; myelin; PO; P2; T cells; IFN-gamma; IL-4;
D O I
10.1016/S0022-510X(97)00178-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
T-lymphocytes are probably involved in the pathogenesis of Guillain-Barre syndrome (GBS). T-helper-1 (Th1) cytokines activate macrophages and induce a delayed type hypersensitivity (DTH) inflammatory response, consistent with the morphology of the demyelination in CBS. Th2 cytokines encourage antibody production and downregulate Th1 responses. To study the Th1/Th2 cytokines in relation to the clinical course of GBS an ELISPOT method for determination of single cells secreting interferon-gamma, IFN-gamma (Th1) or interleukin-4, IL-4 (Th2) was used. We serially investigated antigen-induced cytokine secretion from circulating T-cells stimulated with human peptides from the P0 and P2 proteins in seven patients and compared to results from seven serially investigated healthy controls. Most patients (five of seven) showed IL-4 responses during the plateau- or recovery-phase as compared to controls. One patient with a prolonged disease course, on the other hand, had an IFN-gamma dominated reactivity. We suggest that the IL-4 responses are beneficial in GBS, and may have a role in terminating the disease process in this self-limiting inflammatory disease. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:54 / 60
页数:7
相关论文
共 29 条
[1]  
[Anonymous], 1978, Ann Neurol, V3, P565
[2]   CLINICAL CORRELATION WITH SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN GUILLAIN-BARRE-SYNDROME [J].
BANSIL, S ;
MITHEN, FA ;
COOK, SD ;
SHEFFET, A ;
ROHOWSKYKOCHAN, C .
NEUROLOGY, 1991, 41 (08) :1302-1305
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]   Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barre syndrome [J].
Creange, A ;
Belec, L ;
Clair, B ;
Raphael, JC ;
Gherardi, RK .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 68 (1-2) :95-99
[5]   REVERSE ENZYME-LINKED IMMUNOSPOT ASSAY (RELISPOT) FOR THE DETECTION OF CELLS SECRETING IMMUNOREACTIVE SUBSTANCES [J].
CZERKINSKY, CC ;
TARKOWSKI, A ;
NILSSON, LA ;
OUCHTERLONY, O ;
NYGREN, H ;
GRETZER, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 72 (02) :489-496
[6]   T-LYMPHOCYTE SUBSET ABNORMALITIES IN PERIPHERAL-BLOOD FROM PATIENTS WITH THE GUILLAIN-BARRE-SYNDROME [J].
DAHLE, C ;
VRETHEM, M ;
ERNERUDH, J .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 53 (02) :219-225
[7]   Th1-like responses to peptides from peripheral nerve myelin proteins in patients with polyneuropathy associated with monoclonal gammopathy [J].
Ekerfelt, C ;
Ernerudh, J ;
Vrethem, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (03) :516-522
[8]   TREATMENT OF GUILLAIN-BARRE-SYNDROME WITH ANTI-T-CELL MONOCLONAL-ANTIBODIES [J].
FEASBY, TE .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (01) :51-54
[9]  
HARTUNG HP, 1995, MUSCLE NERVE, V18, P137, DOI 10.1002/mus.880180202
[10]   T-CELL ACTIVATION IN GUILLAIN-BARRE-SYNDROME AND IN MS - ELEVATED SERUM LEVELS OF SOLUBLE IL-2 RECEPTORS [J].
HARTUNG, HP ;
HUGHES, RAC ;
TAYLOR, WA ;
HEININGER, K ;
REINERS, K ;
TOYKA, KV .
NEUROLOGY, 1990, 40 (02) :215-218